Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2015

Jan 8, 2015

6990_dirs_2015-01-08_5ab72d93-14b2-45f5-acb9-de3a8c74859c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2015-01-08

Reporting Person: Gur-Lavie Boaz (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-08 Common Stock A 48332 Acquired 107560 Direct

Footnotes

F1: The shares vest as follows: 25,832 shares - 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter. 22,500 shares will be vested upon goals achievement.